Lahjaouj Meryem, Laachoubi Mohammed, Bouhmadi Khadija El, Oukessou Youssef, Rouadi Sami, Abada Reda, Roubal Mohammed, Mahtar Mohammed
ENT Department, Face and Neck Surgery, Hospital August, 20'1953, University Hospital Center IBN ROCHD, Casablanca, Morocco.
Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, B.P 5696, Casablanca, Morocco.
Ann Med Surg (Lond). 2021 May 14;66:102386. doi: 10.1016/j.amsu.2021.102386. eCollection 2021 Jun.
Chronic rhinosinusitis with polyposis (CRSwNP) is a multifactorial naso-sinusal inflammatory disease that affects 2-4% of the adult population. It highly affects the patient quality of life (QoL) in many levels making it a public health issue. The management of CRSwNP is based on a detailed clinical history, a complete endoscopic examination and a precise computed tomographic (CT) analysis. The aim of this study is to evaluate the prevalence and severity of the various CRS clinical manifestations as well as to highlight the potential relationship between symptom scores, asthma and ESS outcomes.
A retrospective cohort study was performed in the 20 August hospital, between January 2017 and December 2018, on patients diagnosed with CRS according to guidelines recommendations, and were beforehand refractory to initial medical therapy and elected to FESS. The patients were divided into two groups, the first group (G1) of patients with asthma and the second (G2) without asthma in order to expose an eventual significant difference in the improvement of symptoms after surgery. The Sino Nasal Outcome Test-22 (SNOT-22) was used to evaluate QOL.
A total of 100 patients participated in the study with an average age of 44.53 years. The sex ratio was 1.04 (51% men). Asthma was present in 48% of patients while 20% of patients were intolerant to aspirin with a significant difference between the asthmatic and non-asthmatic group (p < 0.05). It appears that asthma was not objectively correlated with a higher Lund Mackay radiological score (p > 0.05). A higher significant improvement was observed between preoperative and postoperative SNOT-22 scores in group with asthma [42.7 ± 16.3 versus 11.8 ± 9.1] and in group without asthma [38.3 ± 15.1 versus 10.5 ± 14.2].
Asthma in CRS is an additional symptom in these patients, mainly reflected in the subset of nasal symptoms in SNOT-22. However, it did not significantly affect the quality of life of the CRSwNP population.
伴息肉的慢性鼻-鼻窦炎(CRSwNP)是一种多因素的鼻-鼻窦炎性疾病,影响2%-4%的成年人口。它在多个层面严重影响患者的生活质量(QoL),使其成为一个公共卫生问题。CRSwNP的治疗基于详细的临床病史、完整的内镜检查和精确的计算机断层扫描(CT)分析。本研究的目的是评估各种CRS临床表现的患病率和严重程度,并突出症状评分、哮喘与鼻内镜鼻窦手术(ESS)结果之间的潜在关系。
2017年1月至2018年12月期间,在8月20日医院对根据指南建议诊断为CRS、先前对初始药物治疗无效并选择接受ESS的患者进行了一项回顾性队列研究。患者分为两组,第一组(G1)为患有哮喘的患者,第二组(G2)为无哮喘的患者,以便揭示手术后症状改善方面的最终显著差异。采用鼻窦结局测试-22(SNOT-22)来评估生活质量。
共有100名患者参与研究,平均年龄为44.53岁。性别比为1.04(男性占51%)。48%的患者患有哮喘,20%的患者对阿司匹林不耐受,哮喘组和非哮喘组之间存在显著差异(p<0.05)。似乎哮喘与较高的伦德·麦凯放射学评分无客观相关性(p>0.05)。哮喘组术前和术后SNOT-22评分[42.7±16.3对11.8±9.1]以及无哮喘组[38.3±15.1对10.5±14.2]之间观察到更高的显著改善。
CRS中的哮喘是这些患者的另一种症状,主要反映在SNOT-22的鼻症状子集中。然而,它并未显著影响CRSwNP人群的生活质量。